Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised.
Most interstitial lung diseases are characterised by inflammation or fibrosis within the …

Abstract Background Research questions To compare the efficacy of nintedanib and
pirfenidone in the treatment of progressive pulmonary fibrosis; and to compare the efficacy of …

Rationale: Incidental parenchymal abnormalities detected on chest computed tomography
scans are termed interstitial lung abnormalities (ILAs). ILAs may represent early interstitial …

Background Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is associated
with high levels of morbidity and mortality. The primary aim of this systematic review was to …

Idiopathic pulmonary fibrosis (IPF) is a progressive disease leading to significant morbidity
and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung …

Interstitial lung disease in patients with anti-neutrophil c... : Current Opinion in Pulmonary
Medicine Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated …

Background: Interstitial lung disease (ILD) evaluation often requires lung biopsy for definite
diagnosis. In recent years, transbronchial cryobiopsy (TBCB) emerged as a procedure with …

Background: Interstitial lung disease (ILD) is a common pulmonary disease often associated
with significant morbidity and mortality in patients with connective tissue diseases (CTD) …

Background: Interstitial lung diseases (ILDs) are a group of heterogeneous diseases
characterized by inflammation and/or fibrosis of the lung interstitium, leading to a wide range …

Introduction Interstitial lung disease (ILD) contributes significantly to morbidity and mortality
in connective tissue disease (CTD). Early detection and accurate diagnosis are essential for …